13-3406(A)(7) The indictment alleges that between January 1, 2026, and April 28, 2026, Holladay obtained money, business, or customers through fraudulent pretenses, including failing to disclose that she was not a licensed medical provider, that SlimSlays had no licensed medical provider authorized to prescribe prescription-only drugs, and that the business had no state-licensed medical director providing legally-mandated clinical oversight
Repeated injections in the same spot can also cause lipohypertrophy, firm lumps that may alter absorption
glycine is added to the C-terminal, and glutathione is born
The GLP-1 Revolution: How Next-Generation Obesity Drugs Are Reshaping Global Healthcare Obesity now affects more than 1 billion people globally, making it one of the most urgent public health and pharmaceutical market opportunities of this decade
Oeltzschner G, Wijtenburg SA, Mikkelsen M, Edden RAE, Barker PB, Joo JH, et al